Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950168-02-000130
Filing Date
2002-02-12
Accepted
2002-02-12 00:00:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.txt S-3 206521
3 CERTIFICATE OF DOMESTICATION dex21.txt EX-2.1 1771
4 CERTIFICATE OF INCORPORATION dex31.txt EX-3.1 11117
5 OPINION OF WYRICK ROBBINS YATES AND PONTON LLP dex51.txt EX-5.1 2437
6 LOAN AND SECURITY AGREEMENT dex1025.txt EX-10.25 193175
7 CONSENT OF INDEPENDENT AUDITORS dex231.txt EX-23.1 1199
  Complete submission text file 0000950168-02-000130.txt   418369
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-82558 | Film No.: 02535635
SIC: 2834 Pharmaceutical Preparations